Advanced Glycation End-Products Induce Connective Tissue Growth Factor-Mediated Renal Fibrosis Predominantly through Transforming Growth Factor β-Independent Pathway
Authors:
- Cai LiCLCai Li
- Lu CaiLCLu Cai
- 1 December 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (6) , 2033-2043
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF‐β1–stimulated porcine skin fibroblastsWound Repair and Regeneration, 2004
- Insights Into the Molecular Mechanism of Chronic Fibrosis: The Role of Connective Tissue Growth Factor in SclerodermaJournal of Investigative Dermatology, 2004
- Angiotensin II Increases Connective Tissue Growth Factor in the KidneyThe American Journal of Pathology, 2003
- The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetesThe FASEB Journal, 2003
- Diabetes and nephropathyCurrent Opinion in Nephrology and Hypertension, 2003
- Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-β1Kidney International, 2003
- Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatmentClinical and Experimental Nephrology, 2003
- Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?Matrix Biology, 2002
- TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cellsAmerican Journal of Physiology-Renal Physiology, 2002
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999